FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Medical Devices

Use Swab Samples of Lesions to Detect Monkeypox: FDA

An FDA safety communication advises that testing for monkeypox virus should use swab samples taken directly from a lesion to avoid false test results.

Federal Register

FDA Revoking Methods of Analysis Regulation

Federal Register proposed rule: FDA proposes to revoke its methods of analysis regulation (21 CFR 2.19) that describes policy to use certain methods o...

Federal Register

FDA Revokes EUA on Covid Detection Kit

Federal Register notice: FDA revokes the emergency use authorization issued to ScienCell Research Laboratories for its ScienCell SARSCoV2 Coronavirus ...

Federal Register

Guide on Instructions for Use Patient Labeling

Federal Register notice: FDA makes available a final guidance entitled Instructions for UsePatient Labeling for Human Prescription Drug and Biological...

Human Drugs

Provepharm NDA for Bludigo Approved

FDA approves a Provepharm NDA for Bludigo (indigotindisulfonate sodium), a diagnostic dye indicated for use as a visualization aid in the cystoscopic ...

FDA General

House Urges Senate to Pass User Fee Reauthorization

The House Energy and Commerce Committee leadership calls on the Senate to urgently reauthorize FDAs user fee programs.

Human Drugs

Hospira Recalls 1 Propofol Lot

Hospira recalls one lot of propofol injectable emulsion due to the presence of a visible particulate in a single retained vial from the lot.

Medical Devices

FDA Wants Patient Safety Info on Software Functions

FDA solicits comments on software functions excluded from the medical device definition by the 21st Century Cures Act.

Human Drugs

Drug Instructions for Use Guidance

FDA publishes a guidance on the content and format of patient instructions for use documents for prescription drugs and biologics.

Federal Register

Genentechs Enspryng Regulatory Review Period

Federal Register notice: FDA determines for patent extension purposes the regulatory review period for Genentechs Enspryng (satralizumab-mwge).